↓ Skip to main content

Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol

Overview of attention for article published in Frontiers in Medicine, August 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
reddit
2 Redditors

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
89 Mendeley
Title
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
Published in
Frontiers in Medicine, August 2020
DOI 10.3389/fmed.2020.00466
Pubmed ID
Authors

Enrico Capochiani, Bruno Frediani, Giorgio Iervasi, Aldo Paolicchi, Spartaco Sani, Paolo Roncucci, Annarosa Cuccaro, Federico Franchi, Federico Simonetti, Davide Carrara, Ilaria Bertaggia, Daniela Nasso, Rossella Riccioni, Sabino Scolletta, Serafina Valente, Edoardo Conticini, Alessandro Gozzetti, Monica Bocchia

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Other 13 15%
Student > Bachelor 10 11%
Researcher 9 10%
Student > Master 5 6%
Student > Doctoral Student 5 6%
Other 16 18%
Unknown 31 35%
Readers by discipline Count As %
Medicine and Dentistry 29 33%
Nursing and Health Professions 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Neuroscience 3 3%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 9 10%
Unknown 37 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2023.
All research outputs
#3,201,725
of 24,216,270 outputs
Outputs from Frontiers in Medicine
#863
of 6,506 outputs
Outputs of similar age
#81,826
of 402,520 outputs
Outputs of similar age from Frontiers in Medicine
#41
of 202 outputs
Altmetric has tracked 24,216,270 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,506 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 402,520 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 202 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.